Form 8-K - Current report:
SEC Accession No. 0001104659-26-064761
Filing Date
2026-05-21
Accepted
2026-05-21 06:03:12
Documents
12
Period of Report
2026-05-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2615235d1_8k.htm   iXBRL 8-K 37647
  Complete submission text file 0001104659-26-064761.txt   251011

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vacc-20260520.xsd EX-101.SCH 3528
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20260520_def.xml EX-101.DEF 26563
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20260520_lab.xml EX-101.LAB 36530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20260520_pre.xml EX-101.PRE 25187
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2615235d1_8k_htm.xml XML 5251
Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 261005796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)